News and Announcements
Proteomics PromarkerD Update
- Published March 07, 2016 12:50PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
7th March 2016, ASX Announcement
Highlights:
- Follow up, validation study on 500 patient cohort underway – results to be announced in due course.
- Company is instigating its own development program to produce a standard clinical pathology In vitro Diagnostic (IVD) test kit for PromarkerD.
- PILL to present to key bio-analytical sector decision markers at invitation only events in the USA this week.
Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to provide the following market update on PromarkerD, the world’s first proteomics-derived predictive (prognostic) test for the diagnosis of Diabetic Kidney Disease.
Partnering and Licensing Progress
PILL remains in ongoing discussions with a number of diagnostic and pharmaceutical companies in global markets, including USA, Europe, Japan and Latin America, for the commercialisation of PromarkerD. As part of this process, PILL has been in discussion with a major global health care company (potential partner) for a period of 11 months in relation to the partnering and licencing of PromarkerD. These discussions continue to progress in a positive manner.
To view the full announcement, please click here.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
